DEFITELIO

Peak

defibrotide sodium

NDAINTRAVENOUSSOLUTIONPriority Review
Approved
Mar 2016
Lifecycle
Peak
Competitive Pressure
0/100

Mechanism of Action

elucidated. In vitro , defibrotide sodium enhances the enzymatic activity of plasmin to hydrolyze fibrin clots. Studies evaluating the pharmacological effects of defibrotide sodium on endothelial cells (ECs) were conducted primarily in the human microvascular endothelial cell line. In vitro ,…

Loss of Exclusivity

LOE Date
Jun 22, 2032
76 months away
Patent Expiry
Jun 22, 2032

Patent Records (5)

Patent #ExpiryTypeUse Code
11085043
Jun 22, 2032
Product
11236328
Jun 22, 2032
U-3301
11746348
Jun 22, 2032
Product
12529052
Jun 22, 2032
Product
12534722
Jun 22, 2032
Product